BCL2 and plasma cell neoplasm: In old animals, the pre-malignant plasmacytosis can then end with monoclonal or oligoclonal plasma cell tumors, and this mouse strain could thus provide a pertinent model for BCL2-driven plasma cell dyscrasia, which is notably a frequent feature of t(11;14) human myeloma cases [47,48].